WS #10474

23:23→23:52 UTC
From 499 msgs · 5 key-dev

Pfizer's Phase 3 trial failure for sigvotatug vedotin in advanced NSCLC is a negative for the company's pipeline.

Pharma Trial Failure

Pfizer's Phase 3 trial failure for sigvotatug vedotin in advanced NSCLC is a negative for the company's pipeline.

Full world state #10474 →

AI Infrastructure and Chip DealsHousing Policy
← WS #10473WS #10475 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|